First infant malaria treatment receives approval: Novartis
ZURICH (AFP)The first malaria treatment for newborns and young infants has received approval from Swiss health regulators, with eight African countries poised to roll the drug out rapidly, pharmaceutical giant Novartis said Tuesday.Malaria is a major killer in Africa, with the continent accounting for 95 percent of the 597,000 deaths from the disease worldwide in 2023, according to the World Health Organization.Of those deaths, about 76 percent -- more than 432,000 -- were children under five, according to the WHO.The infant version of Novartis's Coartem treatment, also known as Riamet, was developed in collaboration with the Medicines for Malaria Venture (MMV), a Geneva-based organisation specialising in research and development of medicines against the disease."Until now, there has been no approved malaria treatment for infants weighing less than 4.5 kilograms (nine pounds 15 ounces)," Novartis said in a statement.The approval from Switzerland's health authority is for a dose designed for babies weighing two to five kilograms.Eight of the countries hit hardest by malaria -- Burkina Faso, Ivory Coast, Kenya, Malawi, Mozambique, Nigeria, Tanzania and Uganda -- participated in the Swiss approval process.The countries are now expected to approve the treatment quickly themselves, under a programme to facilitate access to medicines for low- and middle-income countries, Novartis said.The Swiss pharmaceutical company said it would introduce the treatment "on a largely not-for-profit basis" to increase access in places where the mosquito-borne disease is endemic.
An estimated 263 million people worldwide had malaria in 2023, according to the WHO.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Middle East Eye
a day ago
- Middle East Eye
AFP warns Gaza journalists face starvation amid ongoing Israeli siege
The AFP Journalists' Association has issued a stark warning that its staff in Gaza are at risk of starving to death. One of the 10 freelancers working with the French news agency posted on social media on 19 July: 'I don't have the strength to work for the media. My body is thin and I can't work.' AFP said many of its Gaza-based journalists can no longer carry out their duties due to extreme hunger. 'Their heartbreaking calls for help are now daily,' the association said. While the journalists continue to receive their monthly salaries, AFP noted there is often nothing available to purchase, or basic goods are sold at unaffordable prices. 'We fear we will hear news of their deaths at any moment, and that is unbearable,' the group said. 'Since AFP's founding in August 1944, we've lost colleagues in war zones, seen others wounded or imprisoned—but never have we watched someone die from hunger. We won't accept it.'
Al Etihad
a day ago
- Al Etihad
AstraZeneca says to invest $50 billion in the US
22 July 2025 11:25 LONDON (AFP)British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington.A large chunk of the funds will go toward building a multi-billion-dollar manufacturing centre in Virginia, the company said in a statement, adding that it expects 50 percent of its revenue to come from the United States by 2030."Today's announcement underpins our belief in America's innovation in biopharmaceuticals," the statement quoted CEO Pascal Soriot as President Donald Trump has opened the door to potential tariffs targeting pharmaceuticals, which have so far benefited from exemptions to his sweeping levies on imports from trading ordered an investigation launched into pharmaceutical imports, suggesting that levies could reach up to 200 United States is a key market for the pharmaceutical industry, and AstraZeneca had already announced in April that it had begun transferring part of its European production to the United States. "For decades Americans have been reliant on foreign supply of key pharmaceutical products," US Commerce Secretary Howard Lutnick said in a added that the new tariffs are focused on "ending this structural weakness."The announcement included a new factory in Virginia, which will be the company's "largest single manufacturing investment." Other major pharmaceutical companies, which had been exempt from tariffs for 30 years, have, in recent months, begun shifting investment and production to the United States.
Gulf Today
2 days ago
- Gulf Today
Smartphones before the age of 13 may raise suicidal thoughts, aggression risk in youth: Study
Children who own a smartphone before the age of 13 are more likely to experience poorer mental health and well-being in early adulthood, according to a global study of more than 100,000 young people released on Monday. The study, published in the Journal of Human Development and Capabilities, found that 18- to 24-year-olds who had received their first smartphone at age 12 or younger were more likely to report suicidal thoughts, aggression, detachment from reality, poorer emotional regulation, and low self-worth. Smartphones give early social media access and increase the risks of cyberbullying, disrupted sleep, and poor family relationships by adulthood, the team said. "Our data indicates that early smartphone ownership -- and the social media access it often brings -- is linked with a profound shift in mental health and well-being in early adulthood," said lead author neuroscientist Dr. Tara Thiagarajan, the founder and Chief Scientist of US-based Sapien Labs. Thiagarajan called for urgent action to protect the mental health of future generations, as their symptoms are not the traditional depression and anxiety, and can be missed by studies using standard screening procedures. The researchers urged policymakers to adopt a precautionary approach, similar to regulations on alcohol and tobacco, by restricting smartphone access for under-13s. They also called for mandating digital literacy education and enforcing corporate accountability. In recent years, several countries have banned or restricted the use of cell phones in institutions, including France, the Netherlands, Italy, and New Zealand. Several states in the US have also passed legislation requiring schools to have policies that at least limit access to smartphones for children. For the study, the team at Sapiens mapped the data on 100,000 young adults using the Mind Health Quotient (MHQ) -- a self-assessment tool that measures social, emotional, cognitive, and physical well-being -- to generate an overall mental health score. Young adults who received their first smartphone before age 13 had lower MHQ scores, with scores progressively declining the younger the age of first ownership. Younger ownership was also linked with diminished self-image, self-worth, and confidence, and emotional resilience among females, and lower stability, calmness, self-worth, and empathy among males. "Our evidence suggests that childhood smartphone ownership, an early gateway into AI-powered digital environments, is profoundly diminishing mental health and well-being in adulthood, with deep consequences for individual agency and societal flourishing," Thiagarajan said. Indo-Asian News Service
